The Latest in Conference Coverage

MRI biomarker to be tested in MS

March 9, 2022

Multiple Sclerosis

Ozanimod shows long-term safety, despite a pandemic

March 4, 2022

Multiple Sclerosis

B-cell therapy for MS may impact COVID-19 vaccination

March 3, 2022

Evidence mounts for paramagnetic rim lesions in diagnosing MS

March 2, 2022

Multiple Sclerosis

Spinal cord atrophy predicts ‘silent progression’ in MS

March 2, 2022

Multiple Sclerosis

B-cell repletion is common with MS drug, but no symptom worsening

November 11, 2021

Multiple Sclerosis

Brief, automated cognitive test may offer key advantages in MS

November 10, 2021

Multiple Sclerosis

Specialty pharmacists may speed time to MS treatment

November 10, 2021

Multiple Sclerosis

Cannabis use common for MS-related spasticity

November 3, 2021

Multiple Sclerosis

New consensus guideline on clinical MRI use in MS

November 2, 2021

Multiple Sclerosis

Multiple DMTs linked to alopecia, especially in women

November 1, 2021

Multiple Sclerosis

Certain DMTs in MS linked to more psoriasis

November 1, 2021

Multiple Sclerosis

Which agent is best for neuromyelitis optica?

October 29, 2021

Multiple Sclerosis

Two diets linked to improved cognition, fatigue in MS

October 29, 2021

Multiple Sclerosis

MS and COVID: Docs switched DMTs but maybe didn’t need to

October 29, 2021

Multiple Sclerosis